Although we focused on APOE-independent sources of AD risk, it is important to note that the number of APOE-ε4 alleles had a comparable or even stronger (in the case of amyloid) effect on the outcomes as the polygenic component indexed with a PRS. The gene discussed is APOE; the disease is amyloidosis.